SYNTHEGO

Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health. The company leverages machine learning, automation, and gene editing to build platforms for science at scale. With its foundations in engineering disciplines, the company’s full-stack platform vertically integrates proprietary hardware, software, bioinformatics, chemistries, and molecular biology to advance both basic research and therapeutic... development programs. By providing both commercial and academic researchers and therapeutic developers with unprecedented access to cutting-edge genome engineering, Synthego is at the forefront of innovation, accelerating the development of truly engineered biology. The company was founded in 2012 and is based in Redwood City, California.

#SimilarOrganizations #People #Financial #Event #Website #More

SYNTHEGO

Social Links:

Industry:

Artificial Intelligence Biotechnology Genetics Industrial Automation Innovation Management Life Science Machine Learning Software

Founded:

2012-07-01

Address:

Redwood City, California, United States

Country:

United States

Website Url:

http://www.synthego.com

Total Employee:

251+

Status:

Active

Contact:

Email Addresses:

[email protected]

Total Funding:

459.69 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Domain Not Resolving Apache

Similar Organizations

archerdx-logo

ArcherDX

ArcherDX is a biotechnology firm specializing in cancer research.

codex-dna-logo

Codex DNA

Codex DNA is a biology company helping researchers with the tools they need to securely design, code, and create synthetic DNA.

syros-pharmaceuticals-logo

Syros Pharmaceuticals

Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system

Current Advisors List

doug-carlisle_image

Doug Carlisle Board Member @ Synthego
Board_member

francisco-gimenez_image

Francisco Gimenez Board Observer @ Synthego
Board_observer
2016-10-01

nathaniel-brooks-horwitz_image

Nathaniel Brooks Horwitz Board Observer @ Synthego
Board_observer
2020-01-01

Current Employees Featured

paul-dabrowski_image

Paul Dabrowski
Paul Dabrowski CEO @ Synthego
CEO
2011-12-01

michael-dabrowski_image

Michael Dabrowski
Michael Dabrowski President @ Synthego
President
2012-01-01

robert-deans_image

Robert Deans
Robert Deans Chief Scientific Officer @ Synthego
Chief Scientific Officer
2020-04-01

john-tan_image

John Tan
John Tan Chief Operating Officer @ Synthego
Chief Operating Officer
2020-01-01

aditya-vempaty_image

Aditya Vempaty
Aditya Vempaty VP of Marketing @ Synthego
VP of Marketing
2018-03-01

daniel-mccaffrey_image

Daniel McCaffrey
Daniel McCaffrey Vice President of Data @ Synthego
Vice President of Data
2022-01-24

christopher-covington_image

Christopher Covington
Christopher Covington Senior Software Engineer @ Synthego
Senior Software Engineer
2019-02-01

kevin-holden_image

Kevin Holden
Kevin Holden Head of Science @ Synthego
Head of Science
2019-01-01

Founder

alex-pesch_image

Alex Pesch

michael-dabrowski_image

Michael Dabrowski

paul-dabrowski_image

Paul Dabrowski

Investors List

aafmanagement_image

AAF Management Ltd.

AAF Management Ltd. investment in Series E - Synthego

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series E - Synthego

laurion-capital-management_image

Laurion Capital Management

Laurion Capital Management investment in Series E - Synthego

moore-strategic-ventures_image

Moore Strategic Ventures

Moore Strategic Ventures investment in Series E - Synthego

wellington-management_image

Wellington Management

Wellington Management investment in Series E - Synthego

logos-capital_image

Logos Capital

Logos Capital investment in Series E - Synthego

chimera-investment_image

Chimera Investment

Chimera Investment investment in Series E - Synthego

gigafund_image

Gigafund

Gigafund investment in Series E - Synthego

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Series E - Synthego

declaration-partners_image

Declaration Partners

Declaration Partners investment in Series E - Synthego

Newest Events participated

Participated in Precision Medicine World Conference on 2018-01-22 as exhibitor

Official Site Inspections

http://www.synthego.com Semrush global rank: 444.34 K Semrush visits lastest month: 118.8 K

Host Informations
Whois Informations

Loading ...

More informations about "Synthego" on Search Engine